VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue (VITAL)
Benign Breast Disease
About this trial
This is an interventional other trial for Benign Breast Disease focused on measuring mammographic breast density, breast disease, breast tissue
Eligibility Criteria
Inclusion Criteria:
- part of parent VITAL trial
Exclusion Criteria:
- Men,
- women with breast cancer
Sites / Locations
- Brigham and Women's Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Placebo Comparator
Active Comparator
Active Comparator
Active Comparator
Vitamin D placebo and fish oil placebo
Fish oil and vitamin D placebo
Vitamin D and fish oil placebo
Vitamin D and fish oil
vitamin D placebo + fish oil placebo
Vitamin D placebo and 840 mg of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid [EPA] and 375 mg of docosahexaenoic acid [DHA])
Vitamin D3 (cholecalciferol), 2000 IU per day and fish oil placebo
Vitamin D3 (cholecalciferol), 2000 IU per day and 840 mg of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid [EPA] and 375 mg of docosahexaenoic acid [DHA])